Medtronic credits heart-surgery-device growth as profit tops analyst estimates
Medtronic said it is “starting to see the results” of its investment in new products.
Medtronic beats quarterly profit estimates on strong heart, diabetes device sales
Medtronic beat Wall Street estimates for quarterly profit on Tuesday, on strong demand for its heart and diabetes devices.
Medtronic: Several Reasons For Optimism Before The Upcoming Earnings Release
Medtronic: Several Reasons For Optimism Before The Upcoming Earnings Release
Medtronic (MDT) Increases Yet Falls Behind Market: What Investors Need to Know
In the closing of the recent trading day, Medtronic (MDT) stood at $92.20, denoting a +0.93% change from the preceding trading day.
Seeking Clues to Medtronic (MDT) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
Beyond analysts' top -and-bottom-line estimates for Medtronic (MDT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended January 2025.
Retirement Strategy: 2 Dividend Aristocrats At Bargain Prices
Buying battle-tested dividend aristocrats can be a winning strategy for those seeking durable retirement income. What's even better is if they also carry strong balance sheets and are attractively valued. In this article, I highlight 2 such picks, which, on a combined basis, offer immediate diversification and potential for market-beating total returns.
MDT Stock Trades Cheaper Than Peers Ahead of Q3 Earnings: Time to Buy?
Medtronic expects its fiscal 2025 third-quarter revenues to reflect an unfavorable impact of 1% from currency translation.
Medtronic (MDT) Laps the Stock Market: Here's Why
In the closing of the recent trading day, Medtronic (MDT) stood at $91.69, denoting a +0.79% change from the preceding trading day.
Medtronic (MDT) Outperforms Broader Market: What You Need to Know
In the most recent trading session, Medtronic (MDT) closed at $91.99, indicating a +0.63% shift from the previous trading day.
3 Reasons to Buy Medtronic Stock Like There's No Tomorrow
Shares of Medtronic (MDT 0.32%) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices giant had some weakness in recent years amid disappointing trends from its diabetes segment, but it appears to have finally turned the corner with its increasingly diversified operating profile.
1 Top Dividend Stock to Buy in 2025, and 1 to Avoid
When you're buying income stocks, a company's underlying business is arguably still the most crucial factor to consider, even more than the dividend yield. Corporations with high yields may look attractive, but sometimes these are unsustainable.
Here's How Many Shares of Medtronic You Need to Own to Get $1,000 in Yearly Dividends
If you're a dividend investor, I can understand why -- because dividend-paying stocks offer a triple upside: As long as the underlying company is healthy and growing, its stock price will likely increase over time. It will deliver value to shareholders via a cash distribution, as well, in the form of dividends.
